GAD2 and type 1 diabetes mellitus: By integrating animal experiments, 16S rRNA sequencing, and untargeted metabolomics, this research elucidates the comprehensive protective effects of an orally administered GAD65-L. lactis delivered by NZ9000 L. lactis in T1D intervention.